Annual CFF
$2.14 M
-$745.00 K-25.80%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual cash flow from financing activities is $2.14 million, with the most recent change of -$745.00 thousand (-25.80%) on December 31, 2023.
- During the last 3 years, MXCT annual CFF has fallen by -$26.76 million (-92.59%).
- MXCT annual CFF is now -99.09% below its all-time high of $234.72 million, reached on December 31, 2021.
Performance
MXCT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$228.00 K
-$485.00 K-68.02%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly cash flow from financing activities is $228.00 thousand, with the most recent change of -$485.00 thousand (-68.02%) on September 30, 2024.
- Over the past year, MXCT quarterly CFF has increased by +$191.00 thousand (+516.22%).
- MXCT quarterly CFF is now -99.88% below its all-time high of $184.59 million, reached on September 30, 2021.
Performance
MXCT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$2.14 M
+$191.00 K+9.82%
September 30, 2024
Summary
- As of February 8, 2025, MXCT TTM cash flow from financing activities is $2.14 million, with the most recent change of +$191.00 thousand (+9.82%) on September 30, 2024.
- Over the past year, MXCT TTM CFF has dropped by -$738.50 thousand (-25.68%).
- MXCT TTM CFF is now -99.09% below its all-time high of $234.72 million, reached on December 31, 2021.
Performance
MXCT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MXCT Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -25.8% | +516.2% | -25.7% |
3 y3 years | -92.6% | -81.4% | -26.0% |
5 y5 years | +844.9% | -81.4% | -26.0% |
MXCT Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -99.1% | at low | -84.3% | +516.2% | -99.1% | +53.7% |
5 y | 5-year | -99.1% | at low | -99.9% | +732.1% | -99.1% | +53.7% |
alltime | all time | -99.1% | +396.8% | -99.9% | +732.1% | -99.1% | +53.7% |
MaxCyte Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $228.00 K(-68.0%) | $2.14 M(+9.8%) |
Jun 2024 | - | $713.00 K(+1.4%) | $1.95 M(+40.0%) |
Mar 2024 | - | $703.00 K(+42.6%) | $1.39 M(-35.1%) |
Dec 2023 | $2.14 M(-25.8%) | $493.00 K(+1232.4%) | $2.14 M(-25.5%) |
Sep 2023 | - | $37.00 K(-76.4%) | $2.88 M(-12.4%) |
Jun 2023 | - | $157.00 K(-89.2%) | $3.28 M(-4.9%) |
Mar 2023 | - | $1.46 M(+18.8%) | $3.45 M(+19.5%) |
Dec 2022 | $2.89 M(-98.8%) | $1.23 M(+175.8%) | $2.89 M(+0.6%) |
Sep 2022 | - | $444.40 K(+36.5%) | $2.87 M(-98.5%) |
Jun 2022 | - | $325.50 K(-63.5%) | $187.01 M(+0.2%) |
Mar 2022 | - | $892.60 K(-26.1%) | $186.71 M(-20.5%) |
Dec 2021 | $234.72 M | $1.21 M(-99.3%) | $234.72 M(+0.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $184.59 M(>+9900.0%) | $233.51 M(+377.3%) |
Jun 2021 | - | $27.40 K(-99.9%) | $48.93 M(+0.1%) |
Mar 2021 | - | $48.90 M | $48.90 M |
Dec 2020 | $28.90 M(+134.8%) | - | - |
Dec 2019 | $12.31 M(+5328.0%) | - | - |
Dec 2018 | $226.80 K(-99.1%) | - | - |
Dec 2017 | $23.90 M(+101.4%) | - | - |
Dec 2016 | $11.87 M(-1743.7%) | - | - |
Dec 2015 | -$722.10 K(-115.3%) | - | - |
Dec 2014 | $4.72 M(<-9900.0%) | - | - |
Dec 2013 | -$46.30 K(-103.4%) | - | - |
Dec 2012 | $1.37 M | - | - |
FAQ
- What is MaxCyte annual cash flow from financing activities?
- What is the all time high annual CFF for MaxCyte?
- What is MaxCyte annual CFF year-on-year change?
- What is MaxCyte quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for MaxCyte?
- What is MaxCyte quarterly CFF year-on-year change?
- What is MaxCyte TTM cash flow from financing activities?
- What is the all time high TTM CFF for MaxCyte?
- What is MaxCyte TTM CFF year-on-year change?
What is MaxCyte annual cash flow from financing activities?
The current annual CFF of MXCT is $2.14 M
What is the all time high annual CFF for MaxCyte?
MaxCyte all-time high annual cash flow from financing activities is $234.72 M
What is MaxCyte annual CFF year-on-year change?
Over the past year, MXCT annual cash flow from financing activities has changed by -$745.00 K (-25.80%)
What is MaxCyte quarterly cash flow from financing activities?
The current quarterly CFF of MXCT is $228.00 K
What is the all time high quarterly CFF for MaxCyte?
MaxCyte all-time high quarterly cash flow from financing activities is $184.59 M
What is MaxCyte quarterly CFF year-on-year change?
Over the past year, MXCT quarterly cash flow from financing activities has changed by +$191.00 K (+516.22%)
What is MaxCyte TTM cash flow from financing activities?
The current TTM CFF of MXCT is $2.14 M
What is the all time high TTM CFF for MaxCyte?
MaxCyte all-time high TTM cash flow from financing activities is $234.72 M
What is MaxCyte TTM CFF year-on-year change?
Over the past year, MXCT TTM cash flow from financing activities has changed by -$738.50 K (-25.68%)